Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants

The direct oral anticoagulants (DOACs) have now supplanted vitamin K antagonists (VKAs) for the treatment of venous thromboembolism (VTE). The DOACs include dabigatran, which inhibits thrombin, and rivaroxaban, apixaban, and edoxaban, which inhibit factor Xa. The DOACs are as effective for the preve...

Descripción completa

Detalles Bibliográficos
Autores principales: Weitz, Jeffrey I., Jaffer, Iqbal H., Fredenburgh, James C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490483/
https://www.ncbi.nlm.nih.gov/pubmed/28713563
http://dx.doi.org/10.12688/f1000research.11174.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490483/
https://www.ncbi.nlm.nih.gov/pubmed/28713563
http://dx.doi.org/10.12688/f1000research.11174.1

Ejemplares similares